Is Metastatic Disease the Best Setting for Cost-Effectiveness Studies?
published in: Journal of Clinical Oncology
date of publication: 2016-07-18
Cites articles
There is nothing here
Article - wd:Q87940722
There is nothing here
Article - wd:Q87940722